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Microfabrication and nanotechnology have significantly expanded the technological 
capabilities for monitoring and modulating neural activity with the goal of studying the nervous 
system and managing neurological disorders. This feature article initially provides a tutorial-
like review of the prominent technologies for enabling this two-way communication with the 
nervous system via electrical, chemical, and optical means. Following this overview, the article 
discusses emerging high-throughput methods for identifying device attributes that enhance the 
functionality of interfaces. The discussion then extends into opportunities and challenges in 
integrating different device functions within a small footprint with the goal of closed-loop 
control of neural activity with high spatiotemporal resolution and reduced adverse tissue 
response. The article concludes with an outline of future directions in the development and 






In properly functioning nervous tissue, neurons carry electrical signals, termed action 
potentials, through the tissue via a switching of the membrane potential caused by electrically- 
and chemically-gated ion channels embedded in the cell membrane. Although the action 
potential propagating along the length of the neuron is primarily achieved by electrical means, 
neurons communicate with each other at chemical junctions termed synapses via release and 
binding of various neurotransmitters. Through these complex chemical and electrical 
interactions between neurons as well as supporting cells (glia), information is distributed and 
processed in the central nervous system. In neurological disorders, spanning Alzheimer’s to 
epilepsy, significant changes to this delicate neural tissue environment cause extremely 
deleterious effects ranging from memory loss to seizures. Whether this change is in electrical, 
chemical, or other nature, these disruptions possess valuable information for understanding and 
managing the disorders. Along with pharmaceutical and surgical modalities, the use of 
implanted devices to study and treat neurological conditions has been intriguing for both the 
academic and medical communities alike. One reason for this interest is that in order to 
successfully implement more effective treatments for dynamic disease states, such as epilepsy, 
it is necessary to achieve closed-loop control of the underlying physiological mechanisms of 
the disorder. More specifically, a successful device must be able to continuously monitor the 
state of the neural environment and respond by modulating it with an appropriate stimulus. For 
instance, as in the case of epilepsy, the device should keep track of anomalous 
electrophysiological signals and deliver stimuli to suppress a likely seizure[1]. This ability to 
both monitor and modulate the surrounding tissue via a single device, termed multifunctionality, 
has been a central goal of implanted devices for over a decade. To that end, there have been 
impressive advancements in multifunctional device engineering; however, challenges remain 
in combining multiple functions in an implantable device with a small form factor. A quick 




reveals that there are roughly five main approaches[2,3]: electrical[4] , chemical[5] , optical[6,7] , 
acoustic[8,9] , and magnetic[10]. This review focuses specifically on the three modalities 
(electrical, chemical, and optical) that form a direct interface between device and neural tissue.  
  
Electrical interfaces have been used extensively in neuroscience as tools to study neural 
electrophysiology and its manifestations in higher level activities, such as cognition and 
behavior. These interfaces typically consist of electrodes that interact with electrogenic cells 
that modulate their surrounding ionic environment (via action potentials). These collective ionic 
variations, known as field potentials, can be transduced into electrical signals via the electrodes 
or conversely the ionic environment can be influenced by injecting charge through the 
electrodes.  
 
Chemical interfaces, in which biochemical species are either presented to or detected from the 
surrounding biological tissue, are another widely used tool for interacting with neural tissue. 
These interactions can range from simply presenting bioactive molecules on the surfaces of 
devices[11] to releasing such molecules from the device interface itself[12]. These interfaces can 
also monitor the neurochemical environment through direct electrochemical detection and 
microdialysis[13,14].  
 
Optical interfaces are an emerging and transformative method primarily centered around 
optogenetic methods which are at present limited to non-human use[15]. For this approach, cells 
are genetically transformed to express light-sensitive ion channels, where optical stimulation at 
different wavelengths can excite or inhibit specific cell populations. Accompanying the optical 
stimulation front, development of new dyes that can transduce electrophysiological and 




activity[16-19]. Both optical monitoring and modulation has demanded the fabrication of new 
interfaces to maximize the capabilities offered by these molecular approaches[15,20-23]. 
 
Microfabrication technology has revolutionized the field of neural interfaces; however, as the 
need to integrate multiple functions on a single interface becomes more evident, miniaturization 
technology alone has proved to be insufficient. Innovations on the materials front, especially 
the emergence of new nanostructured materials with unique properties (e.g., mechanical, 
electrical, chemical, and optical[12,24-26]), have opened up new avenues to introduce 
multifunctional interfaces for closed-loop control of neural activity. The goal of this review is 
two-fold. We first provide an overview of the current state of miniaturization technology and 
nanostructured materials used in electrical, chemical, and optical monitoring and modulating 
interfaces. We then discuss the methods and challenges in combining these interfaces to achieve 
multifunctionality for closed-loop control of electrical, chemical, and optical neural devices. 
 
 
2. Monitoring Neural Activity 
2.1. Electrical Monitoring 
Electrical interfaces are arguably the most widely utilized tools for studying the nervous system. 
Typically comprised of an electrode that interacts with surrounding electrogenic neural cells, 
the resulting interface formed between the cells and the electrode surface can be represented as 
an equivalent electrical circuit (Figure 1) that captures the essential system parameters. When 
action potentials propagate through a neuron via the opening of ion channels in the cell 
membrane (illustrated by purple lines in Figure 1) a local imbalance of charge is created. 
Combination of this time-varying ionic imbalance from numerous neurons, termed local field 
potential (denoted as en in Figure 1), is then transduced by the neural electrical interface. This 




Attributes such as physiological buffer resistance (Rs), metal (trace) resistance (Rm), shunt 
capacitance (Cs) and amplifier impedance (Za) can typically be ignored for a well-fabricated 
system. The other attributes, such as electrode material resistance (Re), and electrode double-
layer capacitance (Ce) (which together can be represented as electrode impedance (Ze)), 
alongside seal resistance (Rseal) largely dictate the nature of the interface. The reader is directed 
to comprehensive reviews on the neural-electrical interface for additional details[27-31]. For 
intracellular recording techniques, such as patch-clamp and other emerging approaches[28,32-34], 
the electrical properties of the cell membrane and ionic channels become more important. 
However, for the sake of this review, we will mainly focus on extracellular recording 
approaches. In this section, we outline the utility of microfabrication and nanostructured 
materials in improving electrical monitoring of neural activity. 
 
Dating as far back as the 1950s, the monitoring neural activity initially via electrical interfaces 
involved wire electrodes (platinum or iridium) implanted into the brain[35]. These wires with 
typical diameters of 100s of micrometers, consisted of a conducting metal core and an insulating 
sheath and enabled some of the first electrical recordings from neural tissue (Figure 2A)[35-38]. 
In order to sort the spike patterns from different neurons, it became necessary to have multiple 
recording sites, which was addressed by using tetrodes consisting of four thin wire electrodes 
(10s of micrometers in diameter) bundled together into a single implant (Figure 2B) [39]. These 
devices, easily accessible and manufacturable by researchers are still extensively used for 
electrophysiology; however, they nevertheless suffer from a very limited number of recording 
sites and consequently limited neural spiking information. 
 
The emergence of microfabrication technology enabled the production of microelectrode arrays 
with arbitrary geometries patterned on a variety of substrates. These fabrication techniques 




shanks (Figure 2C) and Utah-style pillars (Figure 2D)) for monitoring (and modulating) neural 
electrophysiology[4,40,41]. In vitro systems for studying the electrophysiology of organotypic 
tissues and dissociated neural cell cultures have also benefited from the microfabrication 
technology with the production of planar microelectrode arrays (MEAs) [2,25,28,42,43]. A major 
limitation of these in vitro and in vivo electrode arrays has been the difficulty in obtaining high 
enough signal-to-noise ratio (SNR) for resolving signals from neural cells. This difficulty arises 
partially due to high electrode impedance (Ze), resulting from reduced electrode surface area[27]. 
Additionally, scar tissue that forms after implantation in many cases can lead to significant loss 
of electrode performance due to distancing of neurons from the electrode surface and the scar 
tissue acting as an ionically-insulating layer (i.e., additional resistor in the electrical circuit 
between the neuron and the Re-Ce combination). Adverse tissue response can also result in 
complete device rejection within weeks after implantation, thus further decreasing the 
resolvable signal[44,45].   
 
Utilizing nanostructured material coatings on recording electrodes has become widely accepted 
as a method for decreasing impedance. Coating an electrode surface with a nanostructured 
material dramatically increases surface area and subsequently increases the electrode 
capacitance (Ce) thus decreasing total electrode impedance[27]. Since the electrode material 
resistivity (Re) remains similar between conductive materials and the impedance is mainly due 
to the electrode-electrolyte interfaces (through electric double layer capacitance (Ce)), 
augmenting the area of this interface via nanostructuring is the preferred method for decreasing 
overall electrode impedance. Additionally, this increase in surface area is approximately 
inversely proportional to the feature size of the nanostructured material. This is due to the 
spherical electrode volume increasing as a function of the feature size to the third power (r3) 
and the area increasing as a function of the feature size to the second power (r2), resulting in an 




One of the initial reports using this approach appeared in 1980 with the observation that 
electrochemical platinum deposition onto gold electrodes improved recording performance[46]. 
This process resulted in significant gains in SNR through a reduction in electrode impedance. 
The electrodeposited film growth results in a nanostructured platinum structure with feature 
sizes ranging from 10s to 100s of nanometers (commonly referred to as platinum black) on the 
surface of the electrode and has been shown to reduce impedance to a range of  1 - 100 kΩ at 1 
kHz for electrodes in the 10s-100s of micrometer range (Figure 3A)[46-51]. Although platinum 
black possesses the impressive electrochemical properties of platinum, it suffers from poor 
mechanical stability and is prone to delamination[51]. Therefore, more mechanically-stable 
metals have been investigated through nanostructuring the electrode surface. Some examples 
include iridium oxide[52,53] and titanium nitride[53] which can both be patterned with feature 
sizes ranging in 100s of nanometers, as well as nanostructured gold[54-57] and nanostructured 
platinum[58] which can be fabricated with smaller feature sizes in the 10s of nanometer range. 
These materials have all been shown to reduce impedance to levels of 10s to 100s of kΩ at 1 
kHz for micro-scale electrodes capable of detecting single unit action potentials (Figure 3A)[54-
60]. Since these materials are fabricated through controllable microfabrication techniques, their 
nanostructure can often be precisely tuned by optimizing the processing steps. The ability to 
tune nanostructure feature size is a major advantage over many of the electrochemically-
deposited films that are economical and easily accessible, yet traditionally suffer from poor 
reproducibility of film nanostructure.  
 
Precise control of electrode nanostructure transcends the electrical improvements and creates 
unique opportunities to enhance the electrical interface. There has been significant research 
effort on utilizing nanostructured surfaces to influence cell behavior such as adhesion and 
motility[61-63]. Much of this effort has focused on utilizing nanostructure to control stem cell 




nanostructure to address challenges in neural recording. One of the largest hurdles facing the 
electrical monitoring of neural function via implanted electrodes is the foreign body response 
after implantation[44,45]. There are many in-depth review articles highlighting the cellular 
mechanisms influencing this response[66-68]. Briefly, trauma after implantation (both acute and 
chronic) causes a local inflammatory response, in which activated astrocytes gradually cover 
the electrode surface and deposit extracellular matrix to create a protective barrier between 
neurons and the electrode (Figure 4A)[68]. This scar tissue separates neurons from the electrode 
surface, reducing the recorded signal amplitude (Figure 4B)[44]. To this extent, some of the 
most promising results regarding nanostructured electrical interfaces have been utilizing 
nanostructure to directly control how neural cells adhere and spread over material surfaces. 
Neural cells (both neurons and glia) display a strong response to nanoscale feature sizes, such 
as surface roughness in the range of 30 to 100 nanometers[69], ridge widths in the regime of 500 
to 2000 nanometers[70], as well as surface morphology length scales ranging from 30 to 500 
nanometers (Figure 3B)[54,71,72]. The underlying mechanisms of the cellular response to the 
nanostructure is complex and is a function of various mechanotransduction events[64]. One such 
mechanism is the regulation of focal adhesion formation on by the nanoscale spacing of 
biologically adhesive sites of the material (Figure 3B)[73-76]. Based on this principle, along with 
the notion that neurons and astrocytes form focal adhesion complexes influenced by different 
nanostructure size ranges[77], it is possible to imagine the possibility of differentially controlling 
neural cell response by precisely tuning the underlying substrate nanostructure. Recently, we 
have demonstrated this phenomenon and its ability to not only improve SNR chronically, but 
also to increase the number of active electrodes over the entire duration of a mixed cortical cell 
culture[54]. This nanostructure-mediated functionality taken together with the reduced electrode 
impedance stemming from electrode nanostructuring alone, is a promising demonstration of 
materials-enabled multifunctionality in a small footprint. Another promising avenue of 




materials as implant substrates to obtain a better mechanical matching between the interface 
and the neural tissue. Although this topic is beyond the scope of this review, multiple reviews 
have been recently published highlighting current efforts to utilize soft and stretchable materials 
for reducing chronic implant trauma caused by micro-motion of the electrodes, and for 
improving device interface through more conformal device geometries [24,78-80]. 
 
In tandem, there have been considerable efforts towards the development of non-metallic 
materials for use as electrode coatings with a focus on conducting polymers and carbon-based 
materials[81]. Conducting polymers, most notably poly(3,4 ethylenedioxythiophene) (PEDOT), 
have received significant attention due to their ability to form stable layers with small feature 
sizes of 10s of nanometers through electrochemical deposition[82-85]. Similar to platinum black, 
the conducting polymer layer formed through this method is nanostructured and therefore 
benefits from a significant reduction in impedance to values between 1-10 kΩ at 1 kHz for 
certain geometries (Figure 3A). Additionally, the polymer base of these materials makes an 
ideal scaffold for chemical functionalization and drug release from the polymer film[86-88]. This 
functionality will be covered in the Chemical Modulation section. On the carbon-based 
materials front, the main interest has been around either single-walled or multi-walled carbon 
nanotubes (CNTs) that are attached over a metal or semiconductor substrate and have typical 
feature sizes below 50 nanometers. Depending on how the CNTs are functionalized (vertically 
aligned or stacked), there can be a substantial increase in the electrochemically-accessible 
surface area, thus achieving low electrical impedances of 3 to 55 kΩ at 1 kHz (Figure 3A) [89-
93]. However, the biocompatibility of CNT coatings is yet to be determined[94-96]. Recently, 
graphene, a two-dimensional carbon-based material, has received attention for use in electrical 
interfaces[97,98]. Although graphene is mostly planar and therefore cannot achieve the same 
surface area as CNTs, it has been shown to promote cellular adhesion[99,100]. This attribute is a 




and the electrode (thus increasing seal resistance (Rseal)). In addition, its embodiment as field 
effect transistors (FET) constitutes a new direction for high SNR neural recording seamlessly 
integrated with electronics[28]. The utilization of transistors as interfaces for electrical 
monitoring has seen a rise in popularity within the past few years. These technologies have 
successfully been fabricated using a range of the materials outlined above such as PEDOT and 
graphene interfacing with gold or iridium [28,101-103]. Through a combination of optimal device 
geometries and material selection, FET have shown promise in amplifying the signal from the 
local field potentials via their modulation of gate dielectric polarization and consequently the 
channel conductance of the transistor.  
 
Ultimately, utilizing nanostructured surfaces to improve the fidelity of electrically monitoring 
neural activity has led to important enhancements in our ability to acquire extracellular 
electrical information from neural systems. Nanostructure has played an instrumental role in 
enhancing recording fidelity by both decreasing electrode impedance (Ze), providing cell type 
specific cues via nanostructure, as well as increasing the seal resistance (Rseal) through 
promoting neuronal coupling to the electrode surface.  
 
2.2. Chemical Monitoring 
While neurons manifest their activity via both electrical (action potentials) and chemical 
(neurotransmitters) means, monitoring neural activity has traditionally been focused on 
electrophysiological recordings. In contrast to electrical communication that runs along the 
neuronal branches (i.e., axons, dendrites), chemical communication can influence a volume of 
disconnected neurons at once through the dispersion of neurotransmitters from the synaptic 
cleft to the extracellular space. This, in turn, leads to larger scale activation/inhibition of neural 
circuits. The most prominent chemical monitoring methods are electrochemical-based detection 




fluorescence and electrical)[14] (Figure 5). Briefly, electrochemical methods (voltammetry) 
offer rapid (sub-second) and direct detection of electroactive molecules[5], such as dopamine 
and serotonin, but are prone to selectivity and biofouling issues. On the other hand, 
microdialysis-based sampling can monitor a wider range of molecules ranging from oxytocin 
(hormone important in bonding) to metabolites (such as glucose and lactate), but it has limited 
temporal resolution. In this section, we will focus on these two techniques, with a discussion of 
how micro- and nano-technology have improved the functionality of these chemical monitoring 
modalities. 
 
2.2.1. Electrochemical  
The operation principle of electrochemical monitoring is to apply a certain electrical potential 
(with respect to a reference electrode), which leads to the oxidation or reduction of a molecule-
of-interest, yielding an electrical current, known as faradaic current (Figure 5A)[5]. The 
electrochemical potential at which this oxidation or reduction (redox) event occurs serves as a 
fingerprint for the molecule type. This method requires the molecules-of-interest to be 
electroactive[5]. Some examples of electroactive neuro-relevant molecules include biogenic 
amines (dopamine, norepinephrine, and serotonin)[5,104-106], as well as their metabolites, 
glutamate, and glucose[107]. There are two dominant modes of this technique. The first one is 
constant-potential amperometry wherein, as the name entails, the working electrode is kept at 
a fixed potential and the number of electroactive species (whose oxidation potential lies below 
the applied potential) are oxidized or reduced when they reach the electrode. In this 
electrochemical protocol, there is no capacitive charging current (since the system is non-time-
varying), where capacitive current typically disguises the faradaic current especially in working 
electrodes with large surface areas. Consequently, the number of molecules reduced or oxidized 
can simply be determined by Q = zNF, where Q is the total electrical charge (produced due to 




and F is Faraday constant. However, the shortcoming with this method is that it lacks 
specificity, especially in vivo where there may be multiple electroactive molecules present. This 
method is therefore more suitable for conditions where the molecular content is well known. 
For example, in vitro cell culture, where the types of neurotransmitters present are well 
characterized, this method becomes powerful[104,108,109]. In this example, cells are cultured near 
a working electrode, where neurotransmitters released from vesicles at the axon leak into the 
extracellular space. While some neurotransmitters bind with the receptors on the dendrite to 
stimulate the next cell and some are oxidized at the electrode to yield neurotransmitter release 
information. The transient measurements provide release kinetics information with millisecond 
resolution, the time integral of these events yield the number of neurotransmitters released, and 
the shape of the spikes can be used for qualifying the neurotransmitter type and cell stimulation-
exocytosis delays[14].   
 
An alternative technique is fast-scan cyclic voltammetry, where the potential is varied rapidly 
(100 V/s) across the range that covers the electroactive species. The advantage of this technique 
is that since a potential range is scanned, the different electroactive species can be identified by 
the potentials where a peak is observed. The challenge is that rapid cycling leads to large 
background currents due to capacitive charging, which reduces the signal-to-noise ratio (SNR) 
for the actual molecule detection. In order to mitigate this issue, several post-processing and 
other electrochemical techniques (e.g., square-wave or differential pulse voltammetry) have 
been devised[110]. The most popular neurotransmitter that is monitored with this technique has 
been dopamine, which plays a significant role in diseases such as Parkinson’s and 
schizophrenia[111,112]. Detection of norepinephrine and serotonin have been more challenging 
due to selectivity and electrode biofouling issues. Changing the sweep profile, as well as the 
range, can lead to oxidation of different species due to their different diffusion coefficients, 




modulations, a variety of different neurotransmitters have been detected, such as adenosine 
(which plays a role in regulating brain metabolism) in the presence of common interfering 
molecules such as hydrogen peroxide and ATP[113,114] and methionine-enkephalin (opioid)[115] 
in the presence of catecholamines (e.g., norepinephrine). 
 
The first electrodes used for electrochemical detection were carbon paste electrodes[116] and 
metal wires. However, these systems lacked multiplexing capabilities and led to large tissue 
damage that likely resulted in artifacts in measurements. The onset of microfabrication 
techniques and miniaturization of electrodes generated exciting possibilities. Aside from being 
able to create arrays of electrodes that can monitor neurotransmitters in different anatomical 
regions with high spatial resolution due to smaller electrodes, the reduction of electrode size 
enhanced limits of detection (although with a downside of increasing settling/response time)[117-
119]. One of the significant issues to consider when miniaturizing electrodes is whether the 
material of interest is microfabrication-compatible. For example, while carbon displays good 
biocompatibility and electrical properties, the conventional carbon paste electrode that has been 
the workhorse of electrochemistry could not easily be patterned via microfabrication 
techniques. An advancement over carbon paste has been the carbon fiber electrode[120,121], 
which is typically sealed in a borosilicate glass capillary (~500 µm-diameter) that is prone to 
breakage or in a more robust fused silica capillary (~100 µm-diameter) that can reduce tissue 
damage during implantation[122]. More microfabrication-compatible materials such as gold and 
platinum have replaced carbon, particularly when photolithography is used for creating 
electrochemical arrays. Gold especially benefits from the well-established gold-thiol linker 
chemistry to further functionalize electrodes with capture/reporter moieties such as enzymes. 






Emergence of nanotechnology, particularly the development of nanomaterials, allowed for the 
use of advanced coatings in electrochemical detection. In addition, nanofabrication allowed for 
reducing sensor footprint leading to better multiplexing. Nanostructure, has not only enhanced 
the limits of detection, but also has provided some solutions unique to the nanometers length 
scales[124]. For example, Colinson et al., our group, and others have shown that nanoporous gold 
(np-Au) electrodes remain electrochemically active due to their intrinsic sieving function, 
where large proteins non-specifically adsorb onto the surface of electrode but not efficiently 
seal the pores, therefore small molecules (such as redox molecules) or fibrillar polymers (such 
as short nucleic acids) can permeate the porous electrode to sustain detection performance[125-
127]. Similar to the carbon fiber electrode, carbon nanofibers have found use for both chemical 
and electrophysiological recordings[128]. Nanomaterials can also be seen as an add-on surface 
functionalization (described in Electrical Monitoring section), as a means to increase the 
effective surface area. For example, carbon nanotubes and graphene have been coated on 
various electrodes (e.g., carbon fiber, gold) to enhance limits of detection and selectivity[129]  – 
a good example is dopamine (Figure 6A and B). By leveraging the different charge transfer 
rates of ascorbic acid and dopamine, high selectivity measurements of dopamine in the presence 
of the interfering ascorbic acid has been achieved[130,131]. However, one challenge with 
increased effective surface area is the aforementioned high capacitive current (related to the 
electric double-layer capacitance, Ce, described in the context of recording electrodes) masking 
the faradaic current that is specific to the target molecule. An emerging field, nanofluidics, have 
shown promise in novel detection schemes, where electrochemical cycling of redox reaction in 
nano-cavities can enhance detection performance[132-134]. 
 
The selectivity and specificity have been significantly improved by immobilizing enzymes 
specific to the neurotransmitter-of-interest. In general, the enzymatic action produces hydrogen 




means. This approach also paves the road to detecting neurotransmitters that are not 
electroactive, such as glutamate[107,135], acetylcholine[136], and adenosine[137] (Figure 6C). 
However, multiplexing different hydrogen peroxide-reporter enzyme systems is difficult, since 
it is not possible to distinguish between different enzymes that correspond to signal from 
different target molecules. Although this can be mitigated by immobilizing the enzymes on 
different electrodes in an electrode array to keep track of the enzyme activity at individual 
electrodes. In addition to enzymes, other capture moieties, such as aptamers, have shown 
promise in detecting psycho-stimulants, such as cocaine[138]. 
 
2.2.2 Microdialysis 
Microdialysis is based on collecting a liquid sample, typically through a semipermeable 
membrane (based on a concentration gradient across the membrane) coupled to a small capillary 
tube for further downstream analysis of the dialysate (Figure 5B)[13]. By varying the size cut-
off the semipermeable membrane, where nanoporous materials hold significant promise[139], a 
variety of different molecule sizes can be detected, ranging from energetic molecules like 
glucose to larger proteins such as beta-amyloids[140,141]. However, in order to have enough SNR 
for reliable measurements, a large amount of sample (hence long collection duration) has 
traditionally been necessary. This, together with the latency resulting from molecules traversing 
the semi-permeable membrane driven by the molecular concentration gradient, adversely 
affects temporal resolution. Integrating this technique with capillary electrophoresis (that 
requires less sample volume) has improved detection limits considerably and hence reduced 
sampling times increasing temporal resolution[142]. Another challenge is the diffusion-related 
broadening of the sample fractions as they travel through the dialysis tube, called Taylor 
dispersion. This is an important obstacle to temporal resolution. Droplet-based approaches have 
largely mitigated this sampling/transport problem, where the samples are encapsulated in 




which provides the opportunity to use a wide range of analytical techniques[142-144] (Figure 6E). 
A device architecture, where micro-encapsulation is both used for delivering and sampling 
chemical moieties, has not been used in the context of neuroscience yet, but it has potential to 
be a useful tool to probe neural tissue (Figure 6F).  Microfluidics, where channels with well-
defined dimensions can be patterned on substrates via microfabrication-techniques, have 
drastically improved the microdialysis-based techniques[145]. This has become especially useful 
in on-chip generation of droplets for subsequent on-chip or off-chip detection.  
 
In order to not deplete the fluidic environment of the sampled region (which could adversely 
affect physiological function), push-pull method of infusing physiological buffer via one 
capillary/microfluidic channel, while sampling with another has been employed (Figure 5B 
and 6)[142,146,147]. The probes used for microdialysis are usually a few millimeters long and a 
few hundreds of micrometers in diameter, while the capillary assemblies (such as for push-pull) 
are generally made by hand. Microfabrication technology for microfluidic channel definition 
permit more sophisticated designs without sacrificing precision. There is number of analysis 
methods used for characterizing the constituents of the dialysate. Traditionally, high-
performance liquid chromatography (HPLC) with fluorescent or electrochemical reporters have 
been used, but now liquid chromatography coupled with mass spectroscopy is emerging[148]. As 
is the case for the majority of microfluidic devices, channel clogging is an obstacle to long term 
durability of microdialysis platforms. The semipermeable membrane is also prone to biofouling 
and clogging, yet nanostructured coatings have shown promise in alleviating some of these 
issues. To that end, several monolithic membranes have been devised including, deep-reactive 
ion-etched porous anodic alumina[139] (Figure 6D) and nanoporous polymers obtained by laser-





Taken alongside electrophysiological recordings, the neurochemical information extracted 
from electrochemical and microdialysis approaches create a richer set of data to monitor neural 
activity. As in the case of electrical interfaces, microfabrication and nanostructured materials 
have not only improved the conventional techniques but also gave birth to unique capabilities. 
 
2.3. Optical Monitoring 
Optical monitoring techniques have become a promising modality for investigating neural 
populations in vivo, largely due to advances in microscope technology and the development of 
new fluorescent probes (Figure 7A). As photons are capable of traveling up to 600 µm to 2 mm 
into neural tissue depending on the wavelength of light[3], optical monitoring techniques are 
capable of observing large volumes of tissue with subcellular resolution, and without directly 
interacting with the tissue being interrogated. Additionally, recent advancements in chemistry 
and molecular biology have provided a suite of different fluorescent indicators that can monitor 
different aspects of neural signaling as well as label specific subsets of the neural population or 
subcellular domains. Apart from some newly developed label-free optical recording techniques 
such as stimulated Raman scattering microscopy[150] and detection of fast intrinsic optical 
signals from membrane electromobility-induced cell deformation[151], optical monitoring is 
fundamentally an indirect monitoring technique, as changes to membrane potential or ion flux 
must first be transduced by fluorescent indicators before they can be optically detected. 
Therefore, the fundamental parameters in determining the effectiveness of any optical recording 
modality (i.e., SNR and spatiotemporal resolution) are affected by both the recording device 
and the fluorescent indicator. 
  
In optical monitoring techniques, the SNR is largely dominated by the efficiency and brightness 
of the fluorescent indicator. Unlike electrical recording modalities that monitor a large change 




of photons reach the detector, and if this number of photons become sufficiently small, the SNR 
will be negatively affected due to shot noise[152]. For this case, the SNR is now determined by 
both the change in fluorescence and the number of photons that reach the detector and is given 
by the following equation: 
 SNR= ∆FF0 √n         (1) 
 
where F0 is the baseline fluorescence, ΔF is the change in fluorescence and n is the number of 
photons that reach the detector[153]. To improve the SNR, two parameters can be altered, 
increasing the photon count or improving the relative fluorescence change (ΔF/F0) of the 
fluorescent indicator. Increasing photon count can be accomplished in two relatively simple 
ways, either through increasing the number of fluorescent indicators in a given volume or by 
increasing the excitation intensity. However, neither of these options are ideal, as increasing 
the number of fluorescent indicators can lead to increased background fluorescence and 
metabolic load[153], while increasing the excitation intensity can lead to phototoxicity and 
photobleaching[154]. Additionally, since the SNR is dependent on the square root of the photon 
count, it is typically considered more efficacious to increase SNR through improving the 
relative fluorescence change of the indicators (ΔF/F0). 
  
Using these optical monitoring techniques, it is possible to probe neural activity and the 
structure of the neural tissue. Derivatives of the original green fluorescent protein[155] can be 
genetically expressed in different cell populations and can be used to monitor the structure of 
both neurons[156-158] and glial cells [159,160]. Additionally, transgenic mice have been developed 
that express a wide variety of fluorescent protein emission wavelengths allowing for 
neighboring cells to be labeled with different colors, enabling the tracking of individual cells 




capabilities of optical monitoring techniques is to track individual neuron and glial cells is given 
by the ‘Brainbow’ method, in which the Cre/lox recombination system is used to create cells 
that express a random combination of three to four different fluorescent proteins (XFPs) 
(Figure 7A). This random expression of XFPs leads to the labeling of individual cells with 
more than 90 discernible colors. Monitoring neural activity is typically achieved through 
genetically-encoded fluorescent indicators that monitor either membrane voltage or Ca2+ 
concentration (Figure 7B and C). Monitoring membrane voltage through genetically-encoded 
voltage indicators (GEVIs) is a more direct method of monitoring neural activity and is capable 
of detecting trains of action potentials at a rate of 200 Hz[164]; however, the low brightness of 
most GEVIs limit their in vivo application[165]. Tracking the changes in intracellular Ca2+ 
concentration, has been the gold standard for optical monitoring of neural activity, and has been 
used to investigate a wide variety of neural processes[166-168]. During action potentials, Ca2+ 
concentration can increase over 100-fold due to the opening of voltage gated calcium 
channels[169], and the current generation of genetically-encoded calcium indicators (GECI) are 
capable of transducing individual action potentials and action potential trains[16,17,170]. GECI are 
typically preferred over GEVI because they provide increased SNR and increased brightness; 
however, it is important to note that increases in intracellular Ca2+ concentration does not 
necessarily indicate neural activity as Ca2+ is used for many other intracellular signaling 
pathways. 
 
Improvements in microscopy technology for in vivo applications is a significant driving force 
for the use of optical techniques to monitor neural activity and has been covered in depth by a 
number of excellent reviews[3,20,21]. In short, the goal of all in vivo microscopy technologies is 
to increase the spatial and temporal resolution in addition to increasing recording depth. The 
simplest microscopy method is epifluorescence microscopy, in which the entire focal plane is 




focal plane into the tissue depth[171]. Although this method has the lowest spatial resolution 
(largely due to decreased SNR stemming from background fluorescence), it has excellent 
temporal resolution as the entire 2D field of view is imaged simultaneously. It is therefore 
conducive to mapping neural connections across different brain regions[172]. To improve the 
spatial resolution, confocal laser scanning microscopy uses a pinhole to eliminate out-of-focus 
fluorescence and reduces background noise at the cost of temporal resolution (as the laser needs 
to be scanned across the 2D plane)[173]. Two-photon and multi-photon microscopy improve 
recording fidelity by using femtosecond infrared laser pulses, which have higher penetration 
depths than visible light[174,175]. Additionally, the spatial resolution for these techniques is 
improved due to individual photons not having enough energy to excite a fluorescent indicator. 
The fluorescence therefore is tightly localized at the focal point, where there is enough photon 
density for individual fluorescent indicators to absorb multiple photons. As with confocal laser 
scanning, two-photon microscopy requires the infrared laser to be scanned across the sample 
volume, and thus the improved recording depth and spatial resolution comes at the cost of 
temporal resolution. To improve the temporal resolution of two-photon and multi-photon 
microscopy techniques, a number of approaches have been developed to multiplex the number 
of scanning points including temporal multiplexing[176], wavelength multiplexing[177], and 
holographic multiplane strategies[178]. 
 
2.3.1. Cortical Imaging 
As most of the optics and actuators are located in the microscope assembly, the actual neural 
interface is typically only used to relay optical information. Chronic optical windows are the 
simplest form of optical neural interface and are comprised of a fixed glass slide placed over a 
craniotomy through which optical microscopy images can be recorded[179-182]. Optical windows 




penetrate the neural tissue. Furthermore by using two-photon microscopy, it is possible to image 
through a thinned portion of the skull eliminating any contact between the brain and 
interface[183]. However, even when using multi-photon microscopy, single cell resolution can 
only be maintained to a depth of ~800 µm into the neural tissue[179-181]; therefore, chronic optical 
windows are limited to recording from the surface layer of the cortex. In order to visualize 
neurons deeper within the cortex and at different angles, right angle prisms have been implanted 
into the cortex of mice that provided the capability to observe entire cortical columns[184,185]; 
however, due to the size and geometry of the prisms, they are still limited to cortical imaging. 
 
2.3.2. Deep Brain Imaging 
Beyond ~800 µm, photon scattering becomes prohibitive to imaging at a single cell resolution, 
and therefore implanted neural interfaces are required to reduce the distance that the photons 
need to travel through the tissue (Figure 8). Optical monitoring of deep brain structures is 
typically accomplished through the insertion of microscale optical fibers into the neural tissue. 
The two most common optical fibers used are gradient-index (GRIN) fibers and fiber bundles. 
GRIN fibers provide the best spatial resolution when monitoring deep brain structures, as the 
GRIN fiber acts as a micro lens that can refocus a laser focal point scanned on the proximal end 
of the GRIN fiber into the neural tissue[186]. GRIN fibers are compatible with most microscopy 
techniques and have been used with epifluorescence, confocal and two-photon techniques[187-
190]. However, GRIN fiber diameter is relatively large (ranging from 350 µm to 1000 µm) and 
they are not flexible[191]. An attractive alternative is fiber bundles consisting of thousands of 
closely packed step-index fibers that can be used instead of GRIN fibers to impart flexibility 
and enhance miniaturization[191]. The main drawback of fiber bundles is that the individual 
fibers can only relay light intensity to and from the target tissue, and thus the image is formed 
by combining the fluorescent intensity from each fiber with the reconstruction of each fiber’s 




fiber diameter and spacing. For both GRIN fibers and fiber bundles, the microscopy setup is 
located at the proximal end of the fiber. In the case of confocal and two-photon microscopy, 
the laser is scanned at the proximal end of the fiber and relayed to the neural tissue. An 
alternative to optical fibers is the direct implantation of microfabricated complementary metal–
oxide–semiconductor (CMOS) image sensors[192]. These sensors eliminate the need to insert a 
relatively blunt optical fiber into the neural tissue, and they can be arranged in a similar style to 
the Michigan array to decrease the total implanted footprint. However, CMOS image sensors 
still suffer from poor spatial resolution due to the resolution being determined by the size and 
arrangement of the individual sensors. 
 
Overall, optical monitoring techniques can provide unique information from the other recording 
modalities, most notably the ability to monitor changes to the structural architecture of both 
neurons and glial cells. Additionally, as photons can travel through tissue, optical techniques 
are able to monitor neurons from a greater distance (Figure 8), and the formation of scar tissue 
is less impactful to their functionality. However, ultimately the exact number of fluorescent 
indicators located within a cell is typically not known, and therefore most optical monitoring 
techniques are only suitable for qualitative assessments of neural structure and activation. 
 
2.4 Summary of Interfaces for Monitoring Neural Activity 
Overall, electrical interfaces have been the most popular tools for monitoring neural activity. 
This is in part due to the ease of recording by interfacing neurons to an electrode and relative 
practically in multiplexing the number of electrodes (compared to chemical and optical 
devices). Direct electrochemical monitoring (without functionalization with intermediate 
molecules such as enzymes) of neurotransmitters and metabolites offer similar advantages, yet 
multiplexing these chemical interfaces have not been trivial. Microdialysis-based interfaces are 




of multiple analytes with high specificity. Optical interfaces generally require reporter 
molecules to transduce the signals, which makes them more complicated than electrical and 
chemical interfaces, unless well-defined reporters (such as for calcium signaling) are employed. 
However, optical interfaces allow for monitoring large numbers of neurons at once and may be 
more conducive to in vivo studies. Overall, each modality captures a distinct portion of neural 
activity, which underlines the importance of multifunctional interfaces in obtaining a more 
complete picture of neural circuit operation. 
 
3. Modulating Neural Activity 
3.1. Electrical Modulation 
In addition to monitoring neural activity, electrical interfaces are widely used as a method to 
modulate electrophysiological activity by stimulating the neural tissue. As depicted in Figure 
1, the electrical interface can be represented as electrical coupling of a neural cell to an 
electrode. Although the electrical parameters defined in the context of neuron-electrode 
equivalent circuit (Figure 1) remain important, other critical parameters emerge for the case of 
electrical modulation. These parameters are the mechanism of charge injection (e.g., capacitive 
or faradaic) and the charge injection capacity (CIC), which is defined as the amount of charge 
that can be injected at a given current or potential before inducing irreversible chemical 
reactions at the electrode surface (Figure 9). Both of these mechanisms are dictated by the 
material properties and effective surface area of the electrode. There are multiple reviews on 
the mechanisms of charge injection and their impact on neural tissue[4,193]. In a purely capacitive 
process, charge is transferred via electrically-induced changes in the electrical double-layer at 
the electrode-neuron interface, without the generation or consumption of chemical species. 
Conversely, in the faradaic process, the electrode participates directly in a redox reaction that 




materials have been used to improve electrical modulation of neural tissue through altering the 
properties of the electrical modulating interface. 
 
Similar to the monitoring of neural function, implanted devices for the electrical modulation of 
neural tissue started being investigated in the 1950s and 60s primarily as implantable wire 
electrodes (Figure 2A)[37,38]. These wire implants facilitated the modulation of large tissue 
regions, but given their 100s of micrometer scale it proved difficult to selectively modulate a 
desired tissue region. The first attempts to improve spatial resolution were through the 
implementation of microwire arrays. These arrays consisted of tens of insulated gold wires with 
exposed platinized tips[194]. As a result of the advances in silicon-based microfabrication, 
penetrating implants with micrometer-sized electrode arrays such as the Michigan and Utah 
arrays (Figure 2C and D) have enabled significantly improved selectivity in the modulation of 
the neural tissue. However, as electrode size is reduced to the micrometer scale, the charge 
density at the electrode must be increased to compensate for the reduced surface area. One 
method of achieving higher charge density is simply by increasing the charge being injected 
through the electrode itself. This makes the selection of material charge injection mechanism 
extremely important to avoid electrode breakdown or tissue damage due to production of 
reactive ion species beyond a certain stimulating current. 
 
The limitation imposed by the charge injection mechanism makes certain materials, such as 
gold, less attractive as a stimulating electrode due to their propensity to ionize permanently into 
the solution through faradaic charge injection. Since capacitive charge injection is ultimately 
the safest method to inject current into neural tissue, due to the absence of any chemical 
reactions, ceramics such as titanium nitride as well as carbon-based electrodes that act entirely 
through capacitive injection have seen extensive use[4]. However, since faradaic processes can 




platinum iridium[4], and iridium oxide[48,53,195] which inject charge through pseudo-capacitive 
mechanisms, are some of the most popular material options. Additionally, the conducting 
polymer PEDOT has received attention for stimulation despite it acting primarily through 
faradaic mechanisms. This is primarily due to the reported electrochemical stability of the 
PEDOT films and their diffusion-limited transfer of ions away from the films enabling the 
rebinding of ions inside the polymer without interaction with the external tissue[81,82,86]. 
 
The other mechanism through which charge injection can be improved is by increasing 
electrode CIC. Nanostructuring of electrode surfaces can significantly improve CIC through 
increases in effective surface area. The most commonly used nanostructured surface remains 
electrochemically deposited platinum (platinum black). Platinum black-coated electrodes 
typically have a CIC in a range of 0.3 - 0.4 mC/cm2, which is approximately 50 to 100% larger 
than the CIC of 0.2 mC/cm2 for planar platinum (Figure 10) [48,50,58]. Although the CIC is still 
low, the ease of platinization makes platinum black an attractive method for coating electrode 
surfaces. Another frequently used material, titanium nitride, which acts through purely 
capacitive charge injection, has been shown to achieve a CIC of 0.87 mC/cm2 through 
nanostructuring (Figure 10)[53,196,197]. Further improvements in purely capacitive-based CIC 
have been observed through utilizing carbon nanotube (CNTs) based electrodes. These surfaces 
take advantage of the large electrochemical surface area of CNTs to achieve increased CICs. In 
one example, Wang et al. demonstrated a CIC of 1.6 mC/cm2, approximately four times that of 
platinum black electrodes (Figure 10)[91-93,198]. However, even better electrode performance can 
be observed through the nanostructuring of iridium oxide by altering fabrication parameters to 
create nanoscale roughness on the surface. These nanostructural changes have been shown to 
result in large increases in CIC to over 4 mC/cm2 (Figure 10)[48,53,195]. Finally, the conducting 
polymer PEDOT has gained popularity due to its efficaciousness in both monitoring and 




CNT and titanium nitride functionalized electrodes and offers additional options for the further 
functionalization of the device surface to give multifunctionality[199]. Another approach to 
preserve the multifunctionality of other nanostructured materials is the templating of 
stimulating electrode materials over nanostructured materials. To that end, iridium oxide has 
been conformally electro-deposited on nanoporous gold (np-Au), resulting in a nanostructured 
iridium oxide surface[200]. 
 
As the predominantly utilized method of neural modulation, identifying new methods to 
integrate electrical modulation functionality into existing devices is an important step towards 
building multifunctional interfaces. Utilizing nanostructured materials as electrode coatings to 
attain high charge injection capacities, it has become possible to inject biologically-relevant 
charge densities from micropatterned electrodes with a small footprint while minimizing 
irreversible chemical reactions. 
 
3.2. Chemical Modulation 
Although electrical stimulation has been the most commonly used technique for modulating 
neural activity and optogenetic stimulation has emerged as a tool with previously unimaginable 
capabilities, direct chemical modulation of the neural activity, for example via controlled 
delivery of soluble neuromodulators remains a powerful tool for stimulating the neural tissue. 
To that end, there have been numerous techniques, where external stimuli, such as acoustic or 
magnetic energy, burst drug carrying micelles delivered through blood infusion or 
microinjection into the brain[201]. Chemical modulation through soluble factor delivery has been 
used extensively in the context of reducing astrogliosis, including therapeutics for alleviating 
foreign body response, such as anti-inflammatory agents (e.g., dexamethasone, α-melanocyte 
stimulating hormone (αMSH)) [202-206], neurotrophic factors (e.g., nerve growth factor (NGF), 




(e.g., ciliary neurotrophic factor (CNTF), fibroblast growth factors (acidic and basic, aFGF and 
bFGF), transforming growth factor-β (TGF-β), and glial derived neurotrophic factor (GDNF)) 
[207,208].  Other less common pharmaceutical approaches include anti-TGF, interleukin-10, and 
even antibodies against astroglial markers[209]. Immobilized chemical moieties on surfaces are 
useful in modulating cellular behavior, by either influencing physical properties (e.g., 
hydrophilicity) or direct biochemical activity of the electrodes (via immobilized growth factors 
and/or adhesion biomolecules). Particularly this has found use in reducing immune-reactivity 
of electrodes by surface treatment approaches, particularly the surface-immobilization of 
biomolecules have shown promise in promoting neural growth and attachment[210]. These 
molecules include common extracellular matrix (ECM) elements (e.g., laminin[211] and poly-D-
lysine[44]) and surface recognition molecules (e.g., N-cadherin, NCAM, L1, CHL1) [209,212]. 
Recently, shorter peptides that are reminiscent of larger ECM molecules have not only shown 
to improve neuronal survival, but also hint at the possibility of cell type-specific adhesion[211-
213]. In this section, we focus on approaches for delivering soluble chemical factors to neural 
tissue with a particular emphasis on modulating neural behavior (Figure 11). 
 
3.2.1. Fluidics-Based Delivery Approaches 
Conventionally, brain infusion has been accomplished via cannulas made of materials such as 
steel and glass. Typically, the chemical factor containing fluids are microinjected through this 
cannula via tubing attached to a syringe pump. This has been successful in the delivery of 
therapeutics and transfection agents for gene therapy and optogenetics. For example, a 
neurotrophic factor has been successfully infused into the brain via catheters for management 
of Parkinson disease[214]. However, this technique lacks spatial resolution, especially in probing 
small circuits in the brain. In addition, the insertion of cannula/catheters results in significant 
tissue damage and these systems are not compatible with studies involving moving animals. 




tungsten wire for recording while injecting pharmaceuticals. These electrodes have also been 
used for keeping track of the number of molecules delivered by electrochemically oxidizing a 
reference molecule mixed in with the active molecules as they are leaving the capillary[215].  
 
Introduction of micropatterning techniques led to integration of microfluidic channels into 
electrical probes and allowed for precise infusion of drug molecules into neural tissue. A recent 
review by Sim et al. overviews fabrication techniques, materials, and potential applications of 
microfluidic-based neural probes[216]. An example is a shank electrode with buried microfluidic 
channels, where the electrode tips are coated with platinum[217]. The microfluidic channels can 
be connected to the surface of the probe using etched through-holes for drug delivery and 
simultaneous recording (Figure 12A). Devices that enable multiplexed delivery of different 
pharmaceuticals have been demonstrated[218-220]. Microfluidic probes, similar to other probes, 
have been made of hard materials, such as silicon (better studied microfabrication processes for 
patterning), and soft materials (e.g., SU8[221], polyimide[222], parylene-C[223]) to reduce 
micromotion-related adverse tissue response. For miniaturized systems to be used in moving 
animals, it is essential that the dependence on external components are minimized, therefore 
use of syringe pumps or large external reservoirs is not practical. To that end, there have been 
developments on micropumps[224]. For mechanical pumps, typically there is a diaphragm that 
pushes the liquid out, where the diaphragm can be actuated via thermal, electrostatic, 
electromagnetic, and electrochemical modes. The control of volume and rate of flow, power 
consumption, and non-hazardous actuation are key requirements for all pumps[225]. Another 
important aspect is fluid storage. In addition to there being limited space to include a small 
reservoir, it is also important to ensure the reservoir can safely contain the liquids. Several 
microfabrication strategies have been employed to address this issue, such as check valves, 





3.2.2. Coating-Based Delivery Approaches 
A significant impact/contribution of nanotechnology has been on development of nanoparticle-
based theranostic modalities, where the influence on monitoring can be seen in optical 
monitoring of brain activity. On the therapeutic front, nanoparticles loaded with drug molecules 
have been used for delivering their cargo upon various triggers (optical, magnetic, acoustic, 
thermal). An excellent set of reviews covering nanoparticle-based delivery methods can be seen 
elsewhere[229-233]. In this review, the focus is on nanostructured coating-based modalities. 
Nanomaterials with their high effective surface area for increased loading capacity and tunable 
morphology have provided new avenues for controlled drug delivery to the neural tissue. For 
these types of coatings, where the surface area-to-volume ratio is high, the majority of the 
transport is due to the surface-molecule interactions, which not only results in high loading 
capacity but also enables the ability to control release kinetics via modulating the surface-
molecule interactions by a variety of modalities (e.g., electrical to switch electrode surface 
charge). Our group has demonstrated that nanoporous gold (np-Au) coatings can retain 
physiologically-relevant doses of anti-mitotic small molecules drugs (Ara-C) to suppress 
astrocytic proliferation in an in vitro astrocyte culture model[234]. This molecular release can be 
gated by changing the type and strength of ionic species[235]. The np-Au coatings can also be 
used for capacitive loading and release of ionic small molecule drugs via iontophoresis[236]. 
Abidian et al. used PEDOT nanotubes for electrical release of dexamethasone by varying 
electrochemical potentials[237,238] (Figure 12C). Layer-by-layer deposition is another attractive 
technique that provides precise control of layer thickness of various materials including, carbon 
nanotubes[239]. There are examples of drug-eluting coatings using polymeric coatings on the 
electrodes[203], as well as carbon nanotube-based coatings for release of dexamethasone to 
reduce gliosis[204]. Unfortunately, nanomaterial-based coatings are not attractive options if they 




microfabrication processes. To that end, electrochemical methods, although reproducibility 
may be an issue, can easily be integrated into electrodes where existing electrodes are used as 
working electrodes for nanostructured material growth. Other desirable processes commonly 
used are physical vapor deposition techniques (such as evaporation and sputtering). A universal 
challenge to nanostructured coating-based drug delivery schemes is to reduce molecular release 
during the OFF state. Charged polymer-based structures have reduced the undesirable release 
by strong electrostatic containment of drug molecules on the polymers. Others, such as Cui et 
al., have used polymers (polypyrrole) to cap carbon nanotubes to reduce molecular release of 
dexamethasone via steric hindrance[204]. 
 
Taken together, the miniaturization technology, coupled with the interfacial phenomena 
emerging at the nano-scale materials and channels, have paved the way to miniaturizing 
neuromodulator delivery schemes and enhanced the possibility to integrate them into 
multifunctional neural interfaces for monitoring and modulation of neural activity. 
 
3.3. Optical Modulation 
Advances in optogenetic technologies have elevated the interest in optical techniques to 
modulate neural activity. As optogenetics has become a powerful tool for neuroscientists, there 
have been a number of excellent reviews published[15,22,23,165]. Briefly, optical modulation of 
neural activity is dictated by the genetic expression of light-activated transmembrane ion 
channels (opsins) in targeted neural populations[240]. There are now many different opsins to 
both activate and inhibit neural activity that are excited by many different wavelengths of 
light[241-245]. Additionally, expression of these light-activated ion channels can be targeted to 
specific neural populations, thereby allowing the optical stimuli to selectively modulate the 
neural activity of a specific sub-population of genetically defined neurons even when a large 




the understanding of functional neural anatomy through improved brain mapping[241,246] and 
investigate the roles that specific neural circuits may play in behavior and disease[1,247,248]. 
 
3.3.1. Photon Delivery 
The role of neural interfaces during optical modulation techniques is to deliver light to the 
neuron population of interest at the minimum required irradiance (~1 mW/mm2 for optogenetic 
activation[240]) for optical modulation. As most light-activated ion channels used in optogenetic 
controls respond most strongly to light in the visible spectrum, scattering effects through the 
neural tissue become increasingly significant and substantial attenuation of the optical stimuli 
occurs within a few hundreds of micrometers[40]. Longer wavelength, two-photon stimulation 
is possible with optogenetics to increase the penetration depth of the light source and to achieve 
sub-cellular spatial resolution of the optical stimuli[249-252]. However the single channel 
conductance of individual opsins are generally low and typically have fast kinetics meaning 
that multiple opsins in an area much larger than the typical two-photon excitation volume need 
to be stimulated nearly simultaneously to induce an action potential[253]. While the increased 
spatial resolution from two-photon optical stimulation allows for the modulation of subcellular 
compartments of neurons (e.g., individual dendrites) [249,250], it also requires complex scanning 
and stimulation methods to activate the neuron. Therefore, as optogenetics is already capable 
of selectively activating genetically defined sub-population of neurons, most optical modulation 
approaches involve the use of visible light delivered to relatively large volumes of neural 
tissue[40]. 
  
The most common light delivery interface used during optogenetic studies are commercially 
available optical fibers coupled to external light sources, often with sharpened tips to reduce 
tissue damage during implantation[240,254-256] (Figure 13A). This approach is commonplace as 




illuminate entire brain regions in small animal models[257]. However, optical fibers have several 
drawbacks, as they are fragile, restrict movement, only allow for optical stimulation at a single 
site, and are not compatible with traditional microfabrication techniques. An inexpensive 
alternative is the use of chronic optical windows in conjunction with head-mounted light 
emitting diodes (LEDs) that allow free movement, and are significantly less expensive than 
optical fibers[258,259]. Just as with optical modulation, chronic optical windows are typically 
considered less invasive as the interface is not penetrating the brain, but also are only capable 
of modulating neurons in the cortex. Chronic optical windows are compatible with transparent 
micro-electocotography (µECoG) arrays fabricated from materials such as parylene-C, 
graphene and ITO, which can obtain ECoG recordings from neurons directly beneath the 
recording sites[97,260,261] (Figure 13B). Microscale waveguides have gained increased popularity 
as they can be fabricated using standard microfabrication techniques and can be used to 
optically modulate multiple regions of the brain at any depth. The waveguides are typically 
coupled to an external light source and fabricated using an oxynitride[262,263] or SU8 core[264,265] 
(Figure 13C). Since they are fabricated using traditional microfabrication techniques, the 
waveguides can be multiplexed into Michigan-style[262,264] and Utah-style[266] probe 
configurations. Furthermore, flexible waveguides have been fabricated using two types of 
PDMS to produce a more “biocompatible” interface[267].  
  
An alternative to delivering optical stimulation from an external light source is the direct 
implantation of µLED arrays, which are fabricated using gallium nitride (GaN) on a sapphire 
substrate using standard microfabrication techniques[268] (Figure 13D). These µLEDs and array 
patterns can be fabricated in a variety of geometries to improve the spatial resolution of the 
stimulating light, and the arrays can be designed to modulate a large volume of tissue while 
displacing the smallest volume possible. Additionally, it is now possible to transfer µLED 




immune response[269-271]. However, because LEDs emit non-coherent light, the effective 
penetration depth of the optical stimuli is reduced and therefore the LEDs need to be in closer 
proximity to the target cells. Additionally, thermal management of the device can become an 
issue, especially when large LEDs or closely spaced LEDs arrays are used[272-274]. Furthermore 
the thermal conductivity of the substrate can greatly impact the thermal fluctuations around the 
µLED, with flexible, polymeric substrates concentrating thermal fluctuations due to their lower 
thermal conductivity[274]. 
 
3.3.2. Optical Nanomaterials 
Nanoparticles can be used to optically modulate neural activity in conjunction with or 
independently from optogenetic techniques. Upconverting nanoparticles act in a similar fashion 
to two-photon microscopy-compatible fluorescent indicators, in which they absorb multiple 
photons of infrared wavelength light and emit shorter wavelength light[275-278]. As many popular 
opsins require visible light for activation, these upconverting nanoparticles can improve the 
penetration depth of optical stimuli[275-278]. Alternatively, thin-films formed from HgTe 
nanoparticles have been shown to directly convert optical stimulation to electrical stimulation, 
and could possibly induce optically-modulated neural activity if embedded within the cellular 
membrane[279]. However there are a few barriers to the successful implementation of HgTe 
nanoparticles to induce optically-controlled neural modulation, most notably the cytotoxicity 
of the HgTe nanoparticles and the difficulty of localizing them to the cellular membrane[23]. 
Alternatively, gold nanoparticles can induce optically-controlled neural modulation through the 
conversion of an optical stimuli to heat through surface plasmon resonance[280-282]. Depending 
on the optical stimuli, gold nanoparticles can inhibit neural activity during sustained optical 
illumination through the activation of temperature sensitive potassium ion channels[281], or can 




to cellular membrane capacitance[280,282]. Nevertheless, while gold nanoparticles are considered 
more biocompatible than HgTe nanoparticles, the cytotoxicity of gold nanoparticles is still 
debated[283-285] and localizing them to the appropriate cell membrane in vivo is still considered 
non-trivial[2]. 
  
As optogenetics technology became more mature, optical modulation techniques have become 
the premiere tool to interrogate neural circuits for fundamental neuroscience research. Optical 
modulation is unique in that it is capable of modulating specific subsets of neural populations 
and even subcellular domains of individual neurons. Furthermore, similar to optical monitoring, 
as photons are able to travel through tissue, optical interfaces are less affected by the chronic 
immune response and glial scar formation. However, the use of optical modulation techniques 
requires either the genetic modulation of the target neuron or the use of potentially cytotoxic 
nanoparticles that may impact its translation to the clinical setting.  
 
3.4 Summary of Interfaces for Modulating Neural Activity 
Each interface modality discussed in this section offer unique opportunities to modulate the 
behavior of neural tissue. Similar to the interfaces used for monitoring neural activity, the 
electrical interface is the most commonly used methods for modulation; however, while this 
method is easy to combine with existing recording electrode architectures, it has very low 
spatial and cellular specificity. In addition, it can only be used to trigger neuronal firing. Optical 
interfaces coupled with optogenetic techniques largely mitigates the shortcoming of electrical 
interfaces, as they are able to turn on and off specific neuronal cell types, creating an extremely 
powerful tool for neuroscience. However, the requirement to use viral vectors to transform the 
neuronal cells raises issues in its translation to clinical use.  Interfaces for chemical modulation, 




of complex neurological disorders, such as epilepsy. Advancements in optical and chemical 
modulation modalities are expected to surpass the capabilities of electrical interfaces if their 
ease of use and fabrication can meet that of electrical interfaces. 
 
4. Combinatorial Material Libraries 
A major limitation to determining the correct material attributes for multifunctional interfaces 
and devices is the enormous effort and time required to test combinations of different attributes. 
Therefore, testing each single combination of material attributes (e.g., morphology and 
electrical properties) and establishing relevant controls within the same experiments becomes 
prohibitively cumbersome and costly. In order to mitigate this issue, there has been a push 
towards high-throughput testing platforms or ‘combinatorial material libraries’ that can be used 
to rapidly identify the optimal material attributes for a specific application[286-288]. 
 
Many implementations of combinatorial material libraries have focused on soft biomaterials 
with a focus on regenerative medicine. These libraries have been utilized for characterization 
of hydrogels[289], polymers[290], as well as extracellular matrix components[291] both in 
vitro[292,293] and in vivo[291] (Figure 14). Recently, Beachley et al. demonstrated the patterning 
and fabrication of both 2D and 3D tissue arrays as a high-throughput method to study tissue-
specific cellular responses[293] (Figure 14C). Using the 2D implementation of a tissue-array, 
they investigated the response of both stem cells and melanoma explants to bone, brain, 
cartilage, collagen, lung, and spleen tissues in parallel. The resulting cultures were then studied 
at a proteomic level to provide insight into how these cells differ in their interactions between 
the different tissues. Similarly, Hook et al. have demonstrated two realizations of combinatorial 
material libraries for the investigation of polymers that reduce bacterial adhesion[290], as well as 




combinatorial material libraries to neural interfaces have been limited. Some examples include 
using ECM protein combination to identify compositions and geometries that lead to desired 
cell phenotype (i.e., neuron or astrocyte) upon insoluble factor-induced differentiation of neural 
stem cells[294].    
 
Although many of these material libraries consist primarily of soft biomaterials (e.g., hydrogels, 
tissue, etc.), there have been advancements in fabrication of combinatorial libraries of 
nanostructured materials[286,295]. Recently our group has demonstrated a method to create 
electrode morphology libraries of nanoporous gold (np-Au) to rapidly screen for feature size-
dependent processes. These material libraries were photolithographically patterned and 
subsequently annealed via laser irradiation at different energies to coarsen each np-Au 
morphology to display a prescribed median feature size ranging from 30 to over 400 
nanometers[295] (Figure 14D). In a recent article, we identified a regime of nanoporous gold 
feature sizes that selectively reduced the spreading of astrocytes while not affecting neuronal 
coverage. This selective coupling along with the reduction in impedance from nanostructure 
(compared to planar gold) improved SNR by approximately 50% above the improvements 
already seen over standard np-Au[54]. Additionally, we have also employed our material 
libraries to study how far-field fluorescence from cell-bound fluorophores changes as a function 
of feature size. In this work, we demonstrated that even with identical base material (e.g., gold) 
the scattering due to nanostructure can significantly decrease perceived fluorescence intensity 
from a planar counterpart[296] (Figure 14E and F). This study emphasized that quantitative 
immune-fluorescence should be used with caution when evaluation the influence of 






These recent reports highlight the benefit of studying processes as a function of material 
nanostructure as well as how utilizing higher throughput methodologies such as combinatorial 
material libraries facilitate this investigation. The translation of this approach towards studying 
other processes such as drug release, material functionalization, optical properties, and 
biocompatibility will undoubtedly lead to enhanced discovery of regimes of feature size that 
result in enhanced performance for neural interfaces. 
 
5. System Integration, Closed-Loop Control, and Multifunctionality 
Multifunctionality, which we have previously described as the ability to both monitor and 
modulate neural activity, is a desirable trait for neural implants in both the clinical and research 
setting. In the research setting, it is possible to treat a neural circuit as a system to be 
characterized via systems identification principles, that is, to systematically modulate the 
system and monitor the outcome to develop transfer functions that describe the system behavior. 
In the clinical setting, multifunctional devices promise the ability to monitor the neural tissue 
for pathological signals and respond with an appropriate pharmaceutical or therapy in real 
time[297]. The various modalities described above (electrical, chemical and optical) allow for 
modulation and monitoring neural systems within a rich parameter space, with each modality 
providing certain advantages and limitations. A major remaining challenge is to integrate these 
modalities within a small form factor to ensure functionality without sacrificing spatial or 
temporal resolution and to minimize the chronic immune response to the implant. Here, we 
provide an overview of some of the major considerations when designing multifunctional neural 
interfaces, along with some examples of successful approaches towards this goal. 
  
As can be seen in Figure 15, electrical interfaces commonly constitute the foundation of 
integrated systems for the closed-loop control of neural function. This is partially due to the 




with its compatibility with microfabrication techniques. Electrical monitoring provides a good 
balance between spatiotemporal resolution and device footprint, and therefore has become the 
main modality to monitor neural tissue in multifunctional devices. Electrical monitoring 
interfaces can easily be adapted to produce an electrical signal for the modulation aspect of a 
multifunctional device. This configuration has led to promising implementations as a feedback 
control for modulation[50,298,299]. However, while electrical modulation provides similar benefits 
as electrical monitoring in terms of spatiotemporal resolution and size, when combined with 
electrical monitoring techniques, the electrical stimulation leads to artifacts in the recording 
during and immediately following the stimulation, which introduces a latency in the closed-
loop control[298,300] (Figure 16A). Therefore, a majority of multifunctional devices pair 
chemical or optical modulation with electrical monitoring. There are several examples that 
utilize electrical monitoring as a feedback signal to release a chemical modulator in response to 
a pathologic electrophysiological signal (Figure 16B and E) [88,221,301-303], or incorporate a 
chemical modulating interface to release anti-inflammatory drugs to reduce the chronic immune 
response and increase device longevity[203,205,206]. There are also many examples of neural 
implants that couple electrical monitoring with optical stimulation[260,304-308] (Figure 16C and 
D). These technologies typically revolve around utilizing optogenetic stimulation with 
electrophysiological feedback, and are useful in many fundamental neuroscience studies. 
However, with the advent of new gene editing strategies, new avenues for the treatment of 
diseases can be imagined[1,309]. While it is also feasible to utilize electrical modulation with 
other modalities such as optical and chemical monitoring for the feedback signal, this is less 
common[103,310]. In one system, the monitoring is done via extracellular electrophysiology 
(electrical recording) and voltammetry (neurotransmitter detection), and the stimulation is 
carried out via iontophoresis of neuromodulators[311]. For optical monitoring, a challenge is 
electrode opacity. Materials such as indium tin oxide are commonly used for in vitro 




performance of electrical monitoring interfaces. However, some successful implementations of 
optical monitoring have been achieved through combination with chemical or optical 
modulation[7,312-314]. 
 
Ultimately, the most effective way to create a multifunctional neural implant is to combine two 
or more existing modalities into a single device. Fabrication compatibility becomes the limiting 
factor in this scenario. For devices containing optical fibers or cannulas, fabrication techniques 
compatible with these materials, such as thermal drawing[304] and metallization of an optical 
fiber cladding[315], are necessary. For example, a thermal drawing process was used to fabricate 
a multifunctional fiber, which was capable of optical and chemical modulation through optical 
waveguides and microfluidic channels respectively, and electrical monitoring through 
conductive polymer electrodes[304] (Figure 16C). While these devices are relatively simple and 
economical (thus accessible by researcher) to fabricate, each fiber is only capable of 
interrogating a small volume of neural tissue, the formation of an array of these fibers is time 
consuming, and individual devices are not reproducible (as each device is typically made 
manually). Alternatively, by using microfabrication techniques, multifunctional devices can be 
reproducibly fabricated in a variety of combinations and complex geometries. Some examples 
are Michigan-style probes fabricated from SU8 containing 20 µm-diameter platinum recording 
electrodes with embedded microfluidic channels[221] and a Utah-style array consisting of 
microneedle SU8 waveguides with a metal/polyimide cladding that also functions as recording 
electrodes[266] (Figure 16D and E). However, while these strategies produce multifunctional 
devices, they typically do not embody multifunctional interfaces, as each individual interface 





As multifunctional neural implants are typically designed for long term applications, device 
failure due to the chronic immune response becomes a larger issue. Therefore the ability to 
fabricate a multifunctional interface in the smallest footprint possible is not only important for 
improving spatial resolution, but also for minimizing the inflammatory response[316]. To that 
end interface materials that are capable of both monitoring and modulating neural activity such 
as np-Au, carbon fibers, and conductive polymers are particularly well suited to multifunctional 
applications. Additionally, all three have shown compatibility with microfabrication processes 
and the ability to be incorporated into compliant substrates[317-320]. An excellent example of the 
implementation of a multifunctional neural interface is the ‘bioelectronic neural pixel’[88] 
(Figure 12B and Figure 16B). In this example, an electrophysiological recording of a neural 
tissue slice is used as the feedback signal for triggered release of an inhibitory neurotransmitter, 
GABA, from a polymer reservoir onto the tissue slice, effectively utilizing the nanostructured 
conducting polymer to facilitate this multifunctionality at a single electrode footprint. 
 
6. Outlook & Conclusion 
In this article, we have reviewed several strategies for monitoring and modulating neural 
activity. While the progress on this front is expected to continue, a new front is the 
multifunctional and closed-loop control of neural systems. This is a multifaceted problem that 
involves not only innovations on the devices and materials front, but also on the controls, 
communications, power transfer, and thermal management. For the former, creating devices 
with integrated optical, fluidic, electrical components with high yield and reliability will require 
new fabrication strategies, especially if the components were to be incorporated on soft 
substrates, such as polyimide, SU8, parylene-C, and silicone[321]. Advancements have also been 
made towards realizing true wireless control (both input and output) from an implanted device 
through ultrasonic waves[322]. Another challenge is controlling the modulation, especially via 




depleting. There have been interesting examples of refilling cargo using nucleic acid-based 
carriers[323] and recycling neurotransmitters for sustained cargo[324]. In order to efficiently use 
the limited storage capacity in miniaturized systems, potent neuromodulators and high 
concentrations are used, which necessitates precise dosing of the active molecules. 
Accordingly, there is a need for actuation and control algorithms to attain this. The control 
algorithm development and systems identification concept described in the previous section 
faces the significant challenge of how to treat neural systems that are far from static (i.e., ever-
evolving via their inherent plasticity). To that end, there is no doubt that new theoretical 
frameworks are needed to be able to accurately develop dynamic transfer functions for such 
systems. It is also crucial to underscore the importance regulatory considerations in translating 
neural interface technologies to patients, which will in the end determine whether a technology 
has true clinical value[325,326]. 
  
Additionally, with the ever-expanding repertoire of multifunctional materials, a need has 
emerged for high-throughput platforms to rapidly assess material attributes and their influence 
on device function. As discussed previously, there have been many innovations on this front 
with both in vitro and in vivo combinatorial systems but with a very limited focus on neural 
applications. Further translation of these combinatorial material characterization techniques to 
neural interfaces and subsequently to combinatorial studies in vivo will significantly accelerate 
advancements in the development of new material coatings. Additionally, translating these 
studies to other material dependent areas such as the development of new device substrates 
from materials such as bioactive or smart polymers can further improve the success of 
implanted devices. Ultimately, it is expected that the development of multifunctional systems 
will prove to be essential for the treatment of neurological diseases and that through improving 
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FIGURES & CAPTIONS 
 
 
Figure 1. Equivalent circuit model of the electrical recording interface. The neural 
electrical interface transduces the local field potential (en), which is a combination of signals 
from a volume of neurons. Physiological buffer resistance (Rs), metal trace resistance (Rm), 
shunt capacitance (Cs), and amplifier input impedance (Za) are typically not limiting factors in 
monitoring performance. The seal resistance (Rseal) and electrode impedance (Ze - determined 








Figure 2. Schematic illustrating common electrode geometries. (A) Wire electrode 
consisting of a conducting wire (grey) and insulating sheath (black). (B) Tetrode consisting of 
four conjoined wire electrodes. (C) Michigan style array consisting of electrodes (grey) on a 
single plane of a shank (black). (D) Utah style array consisting of insulated pillars (black) with 






Figure 3. Examples of techniques to enhance electrical monitoring of neural activity. (A) 
(Left) Representative scanning electron micrographs of nanostructured materials (Platinum[327] 
Reproduced per Creative Commons License, Gold[54] Reproduced with permission.  Copyright 
2015, WILEY-VCH Verlag GmbH & Co. KGaA. Carbon Nanotubes[328] Reproduced per 
Creative Commons License, Iridium Oxide[52] Reproduced with permission. Copyright 2004, 
IEEE. Titanium Nitride[53] Reproduced with permission. Copyright 2002, IEEE. 
PEDOT:PSS[82] Reproduced with permission. Copyright 2003, Elsevier B.V.). (Right) 
Representative graph illustrating the relationship between nanoscale feature size (estimated 
from scanning electron micrographs) and electrode impedances normalized to geometric 
electrode area reported in literature for each material. PEDOT:PSS, CNTs, titanium nitride, and 
iridium oxide all stand out with markedly lower electrode impedances compared to gold and 
platinum. However, gold and platinum appear to be fabricated in a significantly larger range of 
nanostructure. (B) Images demonstrating the use of nanostructure to control cellular coupling 
to underlying substrate and alignment. (Left) The effect of nanoscale roughness on the SH-
SY5Y human neuroblastoma cell line[69] (Reproduced with permission. National Academy of 
Science). (Middle) The effect of micro- and nanoscale ridges on PC12 rat adrenal medulla cell 




The effect of nanopatterned surfaces on MC3T3 osteoblast focal adhesion formation[73]. 







Figure 4. Schematic illustrating the adverse tissue response to a stiff intracranial implant. 
(A) Initial penetration and subsequent micro-motion around the implant leads to increased 
inflammatory response around the implant. This response induces astrocytes to a reactive 
phenotype that leads to scarring around the implant surface[78]. Copyright 2016, Nature 
Publishing Group. (B) Visualization of the scar formation around an implanted electrode site. 
Activated microglia (ED1 – red) cluster around the electrode surface leading to encapsulation 
by astrocytes (GFAP – green) which leads to the distancing of neuron cell bodies (NeuN – blue) 
and neuronal processes (NF – purple) from the surface of the electrode. This scarring both 
introduces an ionically-insulating layer to the surface and distances neurons from the electrode, 
which ultimately reduces the ability to effectively monitor signals from the surrounding cells[44]. 






Figure 5. Schematic illustration of chemical interfaces for monitoring neural activity. (A) 
In electrochemical-detection, leaked neurotransmitters from the synaptic cleft and metabolites 
in the interstitial space are oxidized or reduced by applying an electrical potential between a 
working electrode (bare or coated with enzymes that are specific to the analyte of interest) and 
reference electrode. If the analyte is electroactive, at a molecule-dependent potential, an 
electrochemical current is produced due to the oxidation event. This current reveals the number 
of molecules detected, while the corresponding potential serves as an identifier for the analyte. 
(B) In microdialysis, the interstitial space is sampled through the diffusion of analytes through 
a semipermeable dialysis membrane, where the analytes are encapsulated in micro-emulsions 







Figure 6. Examples of chemical monitoring technologies. (A) Scanning electron microscope 
images of insulated fibers of different metals coated with carbon nanospikes (CNS) via plasma-
enhanced chemical vapor deposition: a-c: tantalum; d: Palladium; e: Niobium; f: Nickel. 
Reproduced with permission[329] Copyright 2015, The Royal Society of Chemistry. (B) 
Corresponding cyclic voltammograms displaying characteristic current peaks for dopamine - 
note that fibers without CNS do not reveal a dopamine signal. (C) A microfabricated 
implantable shank that displays multiple platinum electrodes functionalized with enzymes for 




Copyright 2015, Elsevier B.V. (D) A microfabricated shank with buried microchannels for 
microdialysis. The semipermeable membrane is made of deep reactive ion-etched porous 
anodic alumina[139], allows for an integrated membrane as opposed to a secondary polymeric 
coating prone to delamination. (E) A microfluidic circuitry for perfusing the interstitial space 
with artificial cerebrospinal fluid and encapsulating the dialysate via mineral oil-based droplet 
generator. The droplets are interrogated fluorescently downstream. Reproduced with 
permission[143]. Copyright 2015, The Royal Society of Chemistry (F) A “chemistrode” for 
delivering soluble factors to theoretically modulate a region and sample from the same region 






Figure 7. Examples of optical monitoring technologies. (A) Fluorescence images of neural 
cells labeled with different combinations of fluorescent proteins using the ‘Brainbow’ strategy. 
Top row (left to right), image of the cerebellar flocculus of an adult mouse taken using confocal 
sections. 3D digital reconstruction of the outlined region for circuit mapping. 3D reconstruction 
highlighting the connections between different neurons[161]. Reproduced with permission. 
Copyright 2007, Nature Publishing Group. Bottom row (left to right), Image of astrocytes 
labeled using the ‘Brainbow’ strategy showing their tiled structure[161]. Reproduced with 
permission. Copyright 2007, Nature Publishing Group. Image from the Brainbow 3.1 line of 
transgenic mice that allows for the visualization of fine processes through the expression of 
modified XFPs that were better trafficked to the axons and dendrites[162]. Reproduced with 
permission. Copyright 2013, Nature Publishing Group. (B) (Top) Example of the fluorescence 
signal from the GEVIs Ace1Q-mNeon and Ace2N-mNeon. (Bottom) Comparison of concurrent 
optical (blue) and electrophysiological (black) signals from in vivo recordings[332]. Reproduced 
with permission. Copyright 2015, The American Association for the Advancement of Science. 
(C) Comparing the fluorescence response of the GECIs GCaMP6s (top) and GCaMP6s 
(bottom) to loose seal, cell-attached recordings in the visual cortex[170]. Reproduced with 







Figure 8. Representation of the volume of tissue (green) that can be monitored by optical 
interfaces and compared to some common electrical interfaces. The maximum distance from 
the interface that can be monitored is approximately 850 µm for chronic optical windows[180] 
and implanted prisms[185]. For the GRIN fiberscope and fiber bundle, the maximum image depth 
from the end of the fiber is approximately 340 µm[190-192]. As a comparison, electrical interfaces 







Figure 9. Equivalent circuit model of the electrical stimulation interface. During capacitive 
charge injection (green,) there are no chemical species produced or consumed, whereas during 
faradaic charge injection (purple), electrons are transferred between the electrode and 
surrounding media via redox reactions. Note: some materials behave in a pseudocapacitive 
manner (i.e., platinum and iridium oxide[4]) where their redox reactions are stable and no 
diffusion away from the material surface occurs. Since charge injection happens at the material 







Figure 10. Examples of techniques to enhance electrical modulation of neural activity. 
(Left) Representative scanning electron micrographs of nanostructured materials (Platinum[327] 
Reproduced per Creative Commons License, Gold[54] Reproduced with permission.  Copyright 
2015, WILEY-VCH Verlag GmbH & Co. KGaA. Carbon Nanotubes[328] Reproduced per 
Creative Commons License, Iridium Oxide[52] Reproduced with permission. Copyright 2004, 
IEEE. Titanium Nitride[53] Reproduced with permission. Copyright 2002, IEEE. 
PEDOT:PSS[82] Reproduced with permission, Copyright 2003, Elsevier B.V.). (Right) 
Representative graph illustrating the relationship between nanoscale feature size (estimated 
from scanning electron micrographs) and electrode charge injection limits reported in literature 
for each material. Overall, regardless of feature size, iridium oxide exhibits significantly higher 






Figure 11. Schematic illustration of chemical interfaces for modulating neural activity. 
(A) A microfabricated shank with buried microchannels can deliver soluble factors via 
convective fluidic transport. (B) A microfabricated shank, where the electrodes are composed 
of or coated with materials that can retain neuromodulators and either release them. The release 
step can simply be passive diffusive efflux of molecules or it can be triggered by various stimuli 








Figure 12.  Examples of chemical modulation technologies. (A) A microfabricated shank 
with multiple microfluidic channels and corresponding release orifices. The electrical contacts 
on the same shank allow for electrophysiological recordings during fluidic delivery[219]. 
Reproduced with permission. Copyright 2015, The Royal Society of Chemistry (B) A device 
for electrically-triggered delivery of GABA, an inhibitory neuromodulator, and simultaneous 
monitoring of electrophysiological activity at the same site[88]. Reproduced with permission. 
National Academy of Sciences (C) Scanning electron microscope images of a polymer 







Figure 13. Examples of neural interfaces to provide optical stimulation. (A) Schematic of 
optogenetic stimulation using an optical fiber[333]. Reproduced with permission. Copyright 2010, 
Nature Publishing Group. (B) Transparent ECoG array fabricated from parylene C and 
graphene[260]. Reproduced with permission. Copyright 2014, Nature Publishing Group. (C) 
(Top) Example of a multichannel waveguide for the independent optical stimulation of multiple 
sites. (Bottom) Fabrication schematic and cross-sectional image of an individual waveguide[263]. 
Published with permission. Copyright 2010, Optical Society of America. (D) Michigan-style 
microarray with micro-LEDs instead of recording electrodes[272]. Reproduced with permission. 






Figure 14. Representative material libraries for high-throughput screening. (A)  
A biomaterial library for the study of new biomaterials for in vitro cell attachment, where the 
presence of green fluorescence identified differences in cellular reactivity to the biomaterial in 
question.[287]. Reproduced with permission. Copyright 2009, Elsevier Ltd. (B) A material 
library to study bacterial adhesion to polymers aimed at developing new antibacterial adhesive 




bacteria[290]. Reproduced with permission. Copyright 2012, Nature Publishing Group. (C) A 
combinatorial material library consisting of different tissue types. This library of tissues was 
used to study cell reactivity of certain cancers in a tissue type-dependent manner through a 
fluorescence readout[293]. Reproduced with permission. Copyright 2015, Nature Publishing 
Group. (D) A material library of different np-Au feature sizes. Through patterning and laser 
processing libraries with a large number of morphologies can be created[295]. Reproduced with 
permission. Copyright 2016, The Royal Society of Chemistry. Direct applications of the 
nanoporous gold material libraries. These libraries have been used to (E) study the cell type-
dependent adhesion to nanoporous gold as a function of feature size[54]. Reproduced with 
permission. Copyright 2016, Wiley-VCH Verlag GmbH & Co. KGaA., as well as (F) study 
how fluorescence intensity varies depending on reflectivity and surface effects stemming from 







Figure 15. Combinations of modalities on a single footprint. Bolded references have had 
both the monitoring and modulating capabilities of the device demonstrated in vivo. Asterisks 
indicate references that contain devices with multifunctional capabilities that were not explicitly 







Figure 16. Examples of multifunctional neural devices and interfaces. (A) (Top) SEM 
image of a combined electrical stimulating and recording interface with iridium electrodes. 
(Bottom) Recording artifacts directly following the electrical stimulation[298]. Reproduced with 
permission. Copyright 2005, IEEE. (B) (Top) Schematic and image of the “bioelectronic neural 
pixel”. Organic electronic ion pumps are integrated into PEDOT:PSS recording electrodes, and 
release the inhibitory neurotransmitter GABA when a current is applied. (Bottom) Epileptiform 
activity recorded prior to and following the release of GABA from the interface, demonstrating 




Reproduced with permission. National Academy of Science. (C) (Top) Multifunctional 
interface capable of electrical recording and chemical and optical modulation fabricated using 
a thermal drawing process using polymeric materials. A schematic of the different polymer 
layers is shown and (Middle) images of the drawn fiber along with cross-sectional images 
showing the different polymers and optical transmission. (Bottom) The optical transmission 
through the fiber, impedance of the recording electrodes and mechanical stiffness of fiber is 
shown[304]. Reproduced with permission. Copyright 2015, Nature Publishing Group. (D) (Top) 
Fabrication schematic of an array of multifunctional interfaces consisting of a transparent ITO 
electrode and µLED. (Bottom) Images demonstrating the capabilities of the device[334]. 
Reproduced with permission. Copyright 2013, IEEE. (E) Example of a flexible MEA with an 
integrated microfluidic channel for chemical modulation[321]. Reproduced with permission. 
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The capability to monitor and modulate neural activity in a closed-loop fashion is essential 
for studying the nervous system and managing neurological disorders. This feature article 
introduces the prominent technologies for interfacing with the nervous system via electrical, 
chemical and optical means, followed by a discussion of opportunities and challenges in 
developing multifunctional interfaces that embody the three modalities.  
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